Related Experiment Video
Updated: Jul 20, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Management of obstructive sleep apnea syndrome type 1 in children and adolescents - A French consensus
G Aubertin1, M Akkari2, A Andrieux3
1Pediatric Pulmonology, Armand Trousseau Hospital, AP-HP Hospital, Sorbonne University, Paris, 75012, France; Centre de recherche Saint Antoine (CRSA), INSERM UMR-S 938, Paris, 75012, France; Centre de pneumologie de l'enfant, Ramsay Générale de Santé, Boulogne-Billancourt, 92100, France.
Insights
This guidance offers recommendations for managing obstructive sleep apnea syndrome type 1 (OSA1) in children. Diagnosis and individualized treatment, often involving ENT surgery, are key for effective management.
Area of Science:
- Pediatric Sleep Medicine
- Otolaryngology
- Respiratory Medicine
Background:
- Obstructive sleep apnea syndrome type 1 (OSA1) in children presents with nighttime respiratory symptoms.
- Clinical history taking is crucial for suspecting OSA1.
- Hypertrophy of lymphoid tissues is a primary cause in pediatric OSA1.
Purpose of the Study:
- To provide expert recommendations for managing pediatric OSA1.
- To outline diagnostic criteria and therapeutic strategies.
- To emphasize individualized and multidisciplinary care.
Main Methods:
- Consensus-based recommendations from a panel of experts.
- Review of shared clinical experience and published literature.
- Clinical history, otolaryngologist examination (including nasofibroscopy).
Main Results:
- OSA1 diagnosis can be based on clinical history (two nighttime symptoms, including snoring) without mandatory sleep studies.
- Therapeutic management is individualized based on obstruction site.
- ENT surgery is frequently indicated due to lymphoid tissue hypertrophy.
Conclusions:
- Management requires individualized treatment tailored to the obstruction's location.
- Orthodontic and orofacial-myofunctional therapy may be indicated.
- Continuous, multidisciplinary follow-up within a specialist network is essential.
Abstract:
This document is the outcome of a group of experts brought together at the request of the French Society of Sleep Research and Medicine to provide recommendations for the management of obstructive sleep apnea syndrome type 1 (OSA1) in children. The recommendations are based on shared experience and published literature. OSA1 is suspected when several nighttime respiratory symptoms related to upper airway obstruction are identified on clinical history taking. A specialist otolaryngologist examination, including nasofibroscopy, is essential during diagnosis. A sleep study for OSA1 is not mandatory when at least two nighttime symptoms (including snoring) are noted. Therapeutic management must be individualized according to the location of the obstruction. Ear, nose, and throat (ENT) surgery is often required, as hypertrophy of the lymphoid tissues is the main cause of OSA1 in children. According to clinical findings, orthodontic treatment generally associated with specialized orofacial-myofunctional therapy might also be indicated. Whatever treatment is chosen, follow-up must be continuous and multidisciplinary, in a network of trained specialists.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Management of Insomnia
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

